Susceptibility against retrovirus infection is varying among cell types. To explain these gaps, some of host cell factors have been reported to contribute to the suppression of virus replication. Retroviral Gag-like protein Fv-1 [1] [2] [3] [4] has been identified in murine cell to restrict or permit murine leukemia virus (MuLV) infection. Ref-1 [5] [6] [7] [8] and Lv-1 7) have been reported as Fv-1 like factors against human immunodeficiency virus type-1 (HIV-1) or simian immunodeficiency virus (SIV) replication in nonhuman primate cells. Not only nonhuman mammalian cells, some human derived cells also show low HIV-1 replication competence, in spite of high receptors (CD4 and CXCR4) expression levels. Prior to this research, that phenomenon was observed in HIV-1 (IIIB) infection to HeLa (MAGI/CCR5) cell by an indirect immunofluorescence (IF) estimation (checking virus infection positive cell ratio at four days post virus inoculation) (data not shown). Human originated cell lines have adequate factors supporting transcription from long terminal repeat (LTR) on HIV-1 provirus. Preliminary finding suggested that HIV-1 infection was limited at postentry steps prior to integration by human cell factor(s) in MAGI/CCR5 cell.
This research focuses on whether human cell has any system that restricts HIV-1 replication at postentry level, like other primate cells have. To clear this point, I selected two of human originated cells MAGI/CCR5 and GHOST/CXCR4 (or GHOST/CCR5), which had showed remarkable gap of HIV-1 infectivity. The efficiency of provirus DNA formation between MAGI/CCR5 and GHOST/CXCR4 was evaluated. Further, the effect of cellular factor(s) on the activity of HIV-1 reverse transcriptase (RT) was estimated.
To elucidate the interaction of HIV-1 with host cell would be important to discover the tactic for managing HIV-1 replication causing acquired immunodeficiency syndrome (AIDS). Limited trial of highly active antiretrovirus therapy (HAART) due to unfavorable effects to patients also pushed this study to search for cellular factor(s), which could control HIV-1 replication, permanently.
MATERIALS AND METHODS
Cells and Viruses MAGI/CCR5, 9) GHOST/CXCR4 and GHOST/CCR5 cells 10) were cultured in DMEM (ICN, Costa Mesa, CA, U.S.A.) containing 10% of heat inactivated fetal calf serum (FCS) (PAA Laboratories, Linz, Austria) with antibiotics (100 mg/ml of streptomycin and 100 IU/ml of penicillin). Selection medium for MAGI/CCR5 cell {containing 100 mg/ml of G418 (PAA), 50 mg/ml of hygromycin B (Wako, Osaka, Japan) and 50 mg/ml of zeocin (Invirtogen, Carlsbad, CA, U.S.A.)} and for GHOST/CXCR4 and GHOST/CCR5 cells {containing 500 mg/ml of G418, 100 mg/ml of hygromycin B and 50 mg/ml of puromycin (Invitrogen)} were used for 1 week prior to experiment. HIV-1/IIIB 11) was harvested from MOLT-4#8/IIIB cell culture supernatant. It was passed through 0.45 mm pore size filter (Millipore, Bedford, MA, U.S.A.) and used.
Pseudotyped Viruses Construct pNL4-3-luc Ϫ12) was cotransfected with NL4-3 (X4 strain) (pCXN NL4-3), JR-FL (R5 strain) (pCXN2 JR-FL), amphotropic murine leukemia virus (A-MuLV) (pJD1 Ampho) or VSV-G (pCXN VSV-G) expression vector into 293T cell (human embrionic kidney cell) by calcium phosphate precipitation method. Three days post transfection, pseudotyped virus was harvested and got through 0.45 mm filter (Millipore). It was stored at Ϫ80°C until using.
Luciferase Assay Pseudotyped virus infected 2ϫ10 4 of MAGI/CCR5, GHOST/CXCR4 or GHOST/CCR5 cells in 48-wells plate (Iwaki, Funabashi, Japan). Three days after infection, cell was washed with PBS (Ϫ) and lysed with 100 ml of 1ϫlysis buffer (Promega, Madison, WI, U.S.A.). Luciferase activity was measured by luminometer (Lumat LB9501/16; EG&G Berthold, Bad Wildbad, Germany) after mixing 10 ml of lysate with 50 ml of luciferase substrate solution (Promega). Each assay was performed as duplicate test.
Polymerase Chain Reaction (PCR) Analysis IIIB virus (multiplicity of infection to MT-4 cell was 0.1) infected 5ϫ10 5 of MAGI/CCR5 or GHOST/CXCR4 cells in 6-wells plate (Iwaki). Four or six hours post virus infection, cell was harvested and lysed with urea lysis buffer (4.7 M urea, 1.3% SDS, 0.23 M NaCl, 0.67 mM EDTA, 6.7 mM Tris pH 8.0). DNA was isolated by phenol chloroform extraction method followed by ethanol precipitation. PCR was performed in 1ϫPCR buffer (20 mM Tris pH 8.4, 50 mM KCl, 1.5 mM MgCl 2 , 0.2 mM of dNTPs and 0.05 U/ml of recombinant Taq DNA polymerase; Invitrogen) with 0.5 mM of preimers [M667 (5Ј-GGCTAACTAGGGAACCCACTG-3Ј) and M661 (5Ј-CCTGCGTCGAGAGAGCTCTGGTTT-3Ј) primers to amplify provirus DNA (R/gag region), or glo-A (5Ј-ACA-CAACTGTGTTCACTAGC-3Ј) and glo-B (5Ј-CAACTTCA-TCCACGTTCACC-3Ј) primers to amplify b-globin coding DNA sequence]. 13) PCR reaction was programmed as first denature for 5 min at 94°C, followed with 30 cycles of reaction as denature for 1 min at 94°C, as annealing for 1 min at 65°C (R/gag) or at 55°C (b-globin), as extension for 2 min at 72°C, and final extension for 10 min at 72°C. All PCR was done by Takara Thermal Cycler MP (Takara, Kyoto, Japan).
Polyethylene Glycol (PEG) Fusion Equal number of MAGI/CCR5 and GHOST/CXCR4 cells were fused by 1 ml of polyethylene glycol 1500 (PEG1500) (Boehringer Mannheim, Germany) for 1 min at 37°C. Fused cell was selected by culturing with selection medium (DMEM-10% FCS, 500 mg/ml of G418, 100 mg/ml of hygromycin B, 50 mg/ml of zeocin and 50 mg/ml of puromycin) for 1 week. Isolated cell was infected by A-MuLV pseudotyped virus. Infectivity was evaluated by luciferase assay.
Extraction of Cellular Proteins MAGI/CCR5 or GHOST/CXCR4 cell, which was at on the way to of the increase curve, was harvested by EGTA in PBS (Ϫ) and lysed with cell lysis buffer {1% Triton X-100, 20 mM HEPES pH 7.4, 150 mM NaCl, 0.1 mM EGTA, 5% glycerol, 1 mM DTT, protease inhibitor cocktail (Roche, Basel, Switzerland)} on ice for 1 h without homogenation. Cell lysate was ultracentrifuged at 100000ϫg for 1 h at 4°C. The supernatant (soluble fraction of cell lysate) was subjected to RT activity inhibitory assay.
Reverse Transcriptase (RT) Activity Assay Cell lysate was subjected to RT activity assay system (Reverse Transcriptase Assay, non-radioactive; Roche) following by manufacturer's instruction. Two nanograms of recombinant HIV-1 RT was used. Two hours RT reaction was performed with or without one-twelfth volume of lysate at 37°C as total 60 ml volume scale. The intensity of RT activity inhibition was evaluated by colorimetric assay measuring the absorbance at 405 nm with reference wave length at 492 nm.
Endogenous Reverse Transcription (ERT) Assay HIV-1 (IIIB strain: MOLT4/IIIB cell culture supernatant) was concentrated to 100 times by high speed centrifugation (20000ϫg) for 2 h at 4°C. Virus was inactivated by heated at 56°C for 30 min and viral genomic RNA was subjected to ERT assay. Reaction was performed in buffer {50 mM Tris pH 8.0, 100 mM KCl, 10 mM MgCl 2 , 2.5 mM DTT, 0.2 mM dNTPs, and 50 pg/ml recombinant HIV-1 RT (Roche)}, using viral RNA as template: primer for 1 h at 37°C. Specimen lysate was added to RT reaction system. After reaction, proteins were removed by phenol chloroform treatment. Synthesized DNA was precipitated by isopropanol and resuspended with distilled and deionized water (D 2 W). The efficiency of RT reaction was estimated by PCR analysis to quantify provirus DNA (LTR R region) amount as previously described. 14) PCR was performed in 1ϫPCR buffer (20 mM Tris pH 8.4, 50 mM KCl, 1.5 mM MgCl 2 , 0.2 mM of dNTPs and 0.05 U/ml of recombinant Taq DNA polymerase; Invitrogen) with 0.5 mM of preimers {LTR-D1 (5Ј-GGTCTCTCTGGT-TAGACCAGATC-3Ј), and LTR-D2 (5Ј AAGCAGTGGGT-TCCCTAGTTAGC-3Ј)} to amplify 64 base pair long DNA sequence. PCR reaction was programmed in Takara Thermal Cycler MP, as first denature for 5 min at 94°C, followed with 30 cycles of reaction as denature for 1 min at 94°C, as annealing for 1 min 55°C, as extension for 2 min at 72°C, and final extension for 10 min at 72°C.
RESULTS
The Difference of HIV-1 Infectivity Peusdotyped viruses, which were enveloped with NL4-3 (derived from X4 type HIV-1 using CD4 and CXCR4 molecules as receptor), JR-FL (derived from R5 type HIV-1 using CD4 and CCR5 molecules as receptor), A-MuLV (derived from amphotropic murine leukemia virus using PiT-2 molecule as receptor) or VSV-G (derived from vesicular stomatitis virus envelope proteins), infected MAGI/CCR5, GHOST/CXCR4 or GHOST/CCR5 cell. All cells had been confirmed that same level of CD4 and CXCR4 (MAGI/CCR5 and GHOST/ CXCR4) or CCR5 (MAGI/CCR5 and GHOST/CCR5) had expressed on cell surface by FACScan analysis (data not shown). In all cases, much amount of peusdotyped viruses infected GHOST/CXCR4 or GHOST/CCR5 cells than MAGI/CCR5 cell (Fig. 1) . NL4-3 virus infected GHOST/ CXCR4 cell 230 times higher amount than MAGI/CCR5 cell. JR-FL virus infected GHOST/CCR5 cell 280 times higher amount than MAGI/CCR5 cell. Higher amount of AMuLV pseudotyped viruses infected GHOST/CXCR4 cell (72 times) or GHOST/CCR5 cell (52 times) than MAGI/ CCR5 cell. On the other hand, the gaps of infectivity of VSV (VSV-G) to both cell types were not so drastic (24 times [GHOST/CXCR4 cell] and 17 times [GHOST/CCR5 cell] higher than to MAGI/CCR5 cell) than that of retrovirus enveloped pseudotyped viruses (NL4-3, JR-FL and A-MuLV) (Fig. 1) .
Suppression of Provirus DNA Formation in MAGI/ CCR5 Cell Four and six hours after HIV-1 (IIIB virus) in- fection, total DNA was extracted from cell. The total quantity of provirus DNA (R/gag region; late stage reverse transcription products) was estimated by semi quantitative PCR followed by densitometric analysis. At each time points, GHOST/CXCR4 cell had higher amount of provirus DNA than MAGI/CCR5 cell had (Fig. 2 ) (3.5 times at 4 h and 4.8 times at 6 h). This significantly different provirus DNA formation efficiency was detected for 3 d after virus infection by PCR analysis (data not shown). The gap of accumulated provirus DNA amount increased gradually. Furthermore, as a logical consequence, a small quantity of circular DNA (indicating nuclear translocated provirus quantity) was detected in MAGI/CCR5 cell, even large amount of it was observed in GHOST/CXCR4 cell at all time points (data not shown).
Virus infectivity to hybrid cell (MAGI/CCR5 and GHOST/CXCR4 cells) was assessed. As control, homologous fusion cells (MAGI/CCR5 cell alone and GHOST/CXCR4 cell alone) were used. These cells were fused by PEG 1 week prior to experiment and were cultured in selection medium for MAGI/CCR5 cell or GHOST/CXCR4 cell. Homologous fusion cells contained small amount of non-fusion cells in their culture. To keep similar amount of virus entry among hybrid cells, A-MuLV pseudotyped virus was used. A-MuLV pseudotyped virus infected GHOST/CXCR4 cell 58 times higher than MAGI/CCR5 cell. Heterologous hybrid cell showed low susceptibility against virus (A-MuLV) infection (Fig. 3) . Heterologous hybrid cell had 4.2 times higher susceptibility against A-MuLV than MAGI/CCR5 homologous cell, while GHOST/CXCR4 homologous cell marked 14 times higher one than heterologous cell. Susceptibility of heterologous cell against A-MuLV was likely to that of MAGI/CCR5 homologous cell. Infectivities of A-MuLV to MAGI/CCR5 homologous cell or GHOST/CXCR4 homologous cell were similar to those to PEG non-treated MAGI/CCR5 cell or GHOST/CXCR4 cell, respectively. MAGI/CCR5 Cell Carries HIV-1 RT Inhibitory Factor(s) Total cellular proteins were extracted from MAGI/ CCR5 cell on ice. It was subjected to RT activity (2 ng RT per 60 ml assay test) evaluation system to check direct influence on RT activity. MAGI/CCR5 cell lysate keenly inhibited RT reaction by dose dependent manner (Fig. 4) . Surprisingly, GHOST/CXCR4 cell lysate also suppressed RT activity slightly, in dose dependent way, when inactive protein BSA had no modulatory effect on RT activity (Fig. 4) . This suppressive effect by MAGI/CCR5 cell lysate was about 4 to 5 times stronger than that by GHOST/CXCR4 cell one. At all concentrations of lysate (from 0.1 to 0.7 mg/ml), the gap of RT suppressive effect by MAGI/CCR5 lysate or GHOST/ CXCR4 lysate were observed. RT activity was almost blocked by MAGI/CCR5 cell lysate at 0.7 mg/ml concentration, while weaken activity was still detected at 0.7 mg/ml of GHOST/CXCR4 cell lysate additive case (Fig. 4) .
Intact viral RNA was used as template: primer for ERT reaction. HIV-1RT was supplied to the ERT reaction system, exogenously. Synthesized DNA amount was quantified by PCR which followed ERT reaction. It clearly showed the inhibition of reverse transcription from HIV-1 RNA by MAGI/CCR5 cell lysate (Fig. 5) . Lysate inhibited ERT reaction by dose dependent manner ( Fig. 5 ; compared with buffer and lysate lanes of same concentration, 1/8, 2/8, 3/8, respec- 
Fig. 4. Inhibitory Effect of HIV-1 RT by Cellular Lysate
Several concentrations of total cell lysate proteins from MAGI/CCR5 (open circle) or GHOST/CXCR4 (solid circle) cell were subjected to in vitro RT assay. The effect of protein on RT activity at indicated concentration was aligned. Vertical axis means the intensity of RT activity, which was indicated by the aborbance at 405 nm with reference wave length at 492 nm. BSA line (asterisk) show RT reaction case that was added bovine serum albumine fraction V (BSA) (Sigma-Aldrich, St. Louis, MI) which was dissolved in cell lysis buffer in place of cell lysate. One of the representative result from three times similar experiments is shown. tively). Cell lysis buffer had no effect on ERT reaction during 1/8 to 3/8 concentration of total reaction volume.
DISCUSSION
The gap of HIV-1 infectivity between MAGI/CCR5 and GHOST/CXCR4 or GHOST/CCR5 cell was critically analysed by using replication incompetent pseudotyped viruses. Same level of CD4 and CXCR4 or CCR5 expression (confirmed by FACScan analysis; data not shown) can support the adsorption of same amount of X4 type HIV-1 (NL4-3) or R5 type HIV-1 (JR-FL). This fact was confirmed by checking cell associated HIV-1 core antigen (p24) amount (ELISA assays at 1, 2 and 4 hours post virus infection) and HIV-1 specific RNA quantity (RT-PCR analysis at 1 h post virus infection) (data not shown). A-MuLV and VSV-G pseudotyped viruses can be adsorbed to each cells at similar quantity through ubiquitously expressing their receptors. These results indicated that the great discrepancy of virus infectivity ( Fig.  1) was not due to adsorption capacity. Furthermore, not only NL4-3, JR-FL and A-MuLV (fusion mediated entry), but also VSV (endocytosis mediated entry) pseudotyped virus showed different infectivity between MAGI/CCR5 and GHOST/CXCR4 or GHOST/CCR5 cells (Fig. 1) . This result said that the discrepancy of virus infectivity did not depend on virus entry manner. That result had thought to be obtained from some event(s) at post virus penetration steps.
According to them, the progress of following step(s) after virus penetration was focused. After fusion of virus particle (virion) with host cell and release of viral core structure from virion into cytoplasm, HIV-1 genome RNA is converted to provirus DNA by reverse transcriptase (RT). Synthesized and accumulated provirus DNA amount in MAGI/CCR5 and GHOST/CXCR4 cells was compared by PCR analysis (Fig.  2) . It described the gap of provirus DNA formation capacity led the discrepancy of provirus integration quantity and consequential disparity of infectivity. All data obtained by PCR measurement of provirus amount said that reverse transcription process might be a restriction step for HIV-1 replication efficiency in cells (between MAGI/CCR5 and GHOST/ CXCR4).
These results raised two hypotheses. One of them was this discrepancy came from the effect by any factor(s) having MAGI/CCR5 cell suppressed RT activity. The other was that derived from the result of any factor(s) enhancing RT activity in GHOST/CXCR4 cell. To clear this point, MAGI/CCR5 cell and GHOST/CXCR4 cell were fused by PEG to make a factor dominating cell (Fig. 3) . Similar amount of A-MuLV pseudotyped virus could penetrate to each cell types. This experiment confirmed the heterologous hybrid cell got low susceptibility against HIV-1 by management of virus replication at postentry level. It meant the former hypothesis was accurate. This finding said that human originated cell (MAGI/CCR5 cell) also has any factor(s) which block HIV-1 infection at postentry step. The dominance of MAGI/CCR5 cell factor(s) had contributed to decrease susceptibility of heterologous fusion cell against A-MuLV near to MAGI/CCR5 homologous fusion cell level. From PCR results, RT step was thought to be a critical process for regulation of virus replication in MAGI/CCR5 cell. Like the support of this consideration, MAGI/CCR5 lysate directly inhibited HIV-1 RT activity (Fig. 4) . Furthermore, the discrepancies of RT inhibition efficiency (Fig. 4) and accumulated provirus DNA amount (Fig. 2) between MAGI/CCR5 and GHOST/CXCR4 cells were equal.
Regarding to the effect of MAGI/CCR5 lysate on RT activity, one possibility that it has high DNase activity to digest lately synthesized provirus DNA was assumed. However, it never digested viral DNA for 2 h at 37°C (data not shown). This finding meant the RT suppressive activity by cellular lysate was not due to DNase. This conclusion offered the assumption that DNA chain polymerization by RT might be inhibited by cellular factor(s). Further, to elucidate another doubt that that was an artificial result derived from using polyA: oligod T component as template: primer for RT reaction, the effect of MAGI/CCR5 cell lysate on RT elongation from HIV-1's genomic RNA was tested (Fig. 5 ). This result clearly showed the blocking of provirus DNA formation was due to MAGI/CCR5 lysate. It suggested the existence of some cellular factor(s), which restricts HIV-1 replication at a reverse transcription stage.
Whether this RT suppressive activity by clude MAGI/CCR5 cell lysatre was specific and significant effect by some factors was still unclear. To clear this point, cell lysate was fractionated by column. By fractionation of cell lysate using Sephacryl S-300 gel filtration column (Amersham Pharmacia Biotech, Uppsala, Sweden), specific RT suppressive activity was eluted in 300 to 100 kDa fractions (data not shown). By further fractionation using Mono Q anion exchange column (Amersham Pharmacia Biotech), identifiable RT suppressive activity was detected in 0.35 M ion strength eluted fraction (data not shown). However, identification of active factors, which inhibit HIV-1's RT activity in MAGI/CCR5 cell, has been remained for future objective. Despite the unsuccess identification of RT activity suppressive factors, these preliminary results of column fractionations experiments said that RT suppressive effect of MAGI/ CCR5 cell lysate was not nonspecific suppression but derived from some specific factors. Furthermore, not only HIV-1 but also avian myeloblastosis virus (AMV) and moloney murine leukemia virus (MMLV) RT activities were suppressed by MAGI/CCR5 lysate (data not shown). It said the suppressive effect of MAGI/CCR5 lysate was not specific to HIV-1's RT but ubiquitous to retrovirus RT.
HeLa cell usually has low susceptibility against HIV-1 rather than HOS cell.
15) The previous report concluded that
